肺高血压与非帕伦基马限制性肺部疾病相关
Etienne-Marie Jutant1, Marc Humbert2, David Montani2
1Université de Poitiers, CIC-INSERM 1402, IS-ALIVE Research Group, CHU de Poitiers, Service de Pneumologie, F-86000 Poitiers, France.
概括
慢性肺病中的肺高血压 (PH) 现在根据特定的肺部疾病进行分类. 与非肺膜限制性疾病相关的PH需要进一步的研究和有针对性的管理策略.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 慢性肺部疾病中的肺高血压 (PH) (第三组PH) 之前按呼吸系统疾病类型分类.
- 2024年的修订将第3组PH按特定的肺部疾病 (例如COPD,ILD) 进行分类,并引入一个非帕伦基马限制性肺部疾病子组.
研究的目的:
- 对第三组PH的更新分类进行审查,重点关注非帕伦基马限制性肺病.
- 探索这些特定子组的独特的病理生理机制,临床特征和PH的管理.
- 突出研究缺口和未来的方向,PH与非帕伦基马限制性肺部疾病相关.
主要方法:
- 关于PH分类的第七届世界研讨会的文献综述.
- 分析非偏膜性限制性肺病亚型中的病理生理机制.
- 评估当前的管理策略和研究数据对于PH在这个人群.
主要成果:
- 修订后的分类强调了特定的肺部疾病,包括一个新的非体限制性肺部疾病的子组 (例如,低通风综合征,肺切除术).
- 与非帕伦基马限制性肺病相关的PH尽管是早期公认的形式,但仍未得到充分研究.
- 有限的数据存在于批准的肺动脉高血压治疗在这个特定的PH群体的疗效和安全性.
结论:
- 更新的分类为理解和管理3组PH提供了更精确的框架.
- 进一步的研究至关重要,以阐明PH机制,并优化患者的治疗与非体限制性肺部疾病.
- 解决潜在的疾病仍然是管理的主要重点,对这一子组需要基于证据的治疗方法.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
760
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
760
Cardiomyopathy IV: Restrictive Cardiomyopathy
714
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
714
Acute Respiratory Failure-II
1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Other Pulmonary Disorders
1.8K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.8K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
710
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
710
Chronic Obstructive Pulmonary Disease
2.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.9K


